21.00GBP0.00%Mkt Cap: 13.03M GBPP/E: InfinityLast update: 2026-05-21
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufactu…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap13.03M GBP
Enterprise Value10.59M GBP
Revenue (TTM)4.46M GBP
Gross Profit1.78M GBP
Net Income (TTM)-1.44M GBP
Revenue/Share0.0720 GBP
Last Price21.00 GBP
Fiscal Year EndSep 2025
MR QuarterMar 2025
Employees59
CountryGB
SectorHealth Care
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)Infinity
P/E (Forward)-52.50
PEG—
EV/EBITDA38.93
EV/Revenue2.37
P/S2.92
P/B1.83
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
10.4273% of range25.00
52W High25.00 GBP
52W Low10.42 GBP
Profitability
Gross Margin81.06%
Oper. Margin-26.46%
EBITDA Margin6.10%
Profit Margin-65.72%
ROE-20.05%
ROA-17.63%
Growth
Revenue Growth85.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.33M GBP
CapEx (TTM)55.00K GBP
FCF Margin—
FCF Yield—
Net Debt-2.54M GBP
Net Debt/EBITDA-9.33
Balance Sheet
Debt/Equity0.05
Current Ratio4.64
Quick Ratio3.62
Book Value/Sh0.1150 GBP
Cash/Share0.0570 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 1, 2003
Analyst Consensus
Rating—
Target (Mean)50.00 GBP
Target Range50.00 GBP – 50.00 GBP
# Analysts1
Ownership
Shares Out.62.06M
Float50.72M
Insiders50.62%
Institutions22.37%
Technical
SMA 5017.15 (+22.5%)
SMA 20013.70 (+53.3%)
Beta0.97
S&P 52W Chg27.23%
Avg Vol (30d)334.64K
Avg Vol (10d)486.26K
Technical Indicators
RSI (14)61.3
MACD1.8906
MACD Signal1.6738
MACD Hist.+0.2167
BB Upper23.59 GBP
BB Middle19.39 GBP
BB Lower15.19 GBP
BB Width43.34%
ATR (14)1.478 GBP
Vol Ratio (20d)0.99x